ERA-EDA Symposium 2018

Read story

ESC Congress 2017

Read story

ERA-EDTA Congress 2017

Read story

ESC Congress 2016

Read story

EASD 2016

Read story

European Biopharmaceutical Review

Read story

New York Academy of Science Symposium

Read story

The Complement System: Part 1

Read story

The Complement System: Part 2

Read story

The Complement System: Part 3

Read story

Diabetes Mellitus

Read story

Chronic Kidney Disease

Read story

The New Frontier of Epigenetics

Read story

Readers, Writers & Erasers in Epigenetics

Read story

Clinical Trials Series: Part 1

Read story

Clinical Trials Series: Part 2

Read story

Clinical Trials Series: Part 3

Read story

Pharmacoeconomics

Read story

Sanofi Biogenius Competition CTV News feature

Read story

World Diabetes Day

Read story

ERA-EDA Symposium 2018

In spring of 2018, we hosted a symposium at the European Renal Association – European Dialysis and Transplant Association (ERA‐EDTA) Congress in Copenhagen, Denmark. The symposium, "Epigenetics in CKD & CVD: A potential breakthrough therapy”, highlighted the unmet need for a novel approach to reduce risk in kidney and cardiovascular disease, and demonstrated the important role for epigenetics in the underlying pathology of these diseases. Speakers included: Vincent M Brandenburg, MD – University Hospital of the RWTH Aachen, Germany; Eric Stroes, MD – Academic Medical Centre, Amsterdam, The Netherlands; Louise Nordfors, PhD – Karolinska Institute, Stockholm, Sweden and; Kamyar Kalantar‐Zadeh, MD – UC Irvine School of Medicine, Irvine, USA. These renowned experts in the field of CKD presented on topics including, “Cardiovascular disease in diabetes and CKD & residual risk ‐ The promise of epigenetics”, “Epigenetics in CKD: Rationale for BET inhibition, an emerging therapeutic mechanism in renal disease and CVD”, and “A clinical view on BET inhibition in CKD & CVD: Understanding recent data and future perspectives”.

The video presentations and symposium highlights can be accessed here.